病例报告

以血小板减少、脾大为首发表现的肝豆状核变性1例

  • 闫晓倩 ,
  • 杨洁 ,
  • 杨永宾 ,
  • 陈钰 ,
  • 李燕 ,
  • 李杰
展开
  • 1.河北北方学院研究生院,张家口 075132
    2.河北省人民医院血液科,石家庄 050051
    3.河北省人民医院血管外科,石家庄 050051
    4.河北医科大学研究生院,石家庄 050051
杨 洁,副主任医师,硕士;电子信箱:yjyyb313@163.com

收稿日期: 2025-11-14

  录用日期: 2025-12-31

  网络出版日期: 2026-04-10

A case report of Wilson's disease presenting with thrombocytopenia and splenomegaly as the inital manifestations

  • Yan Xiaoqian ,
  • Yang Jie ,
  • Yang Yongbin ,
  • Chen Yu ,
  • Li Yan ,
  • Li Jie
Expand
  • 1.Graduate School of Hebei North University, Zhangjiakou 075132, China
    2.Department of Hematology, Hebei General Hospital, Shijiazhuang 050051, China
    3.Department of Vascular Surgery, Hebei General Hospital, Shijiazhuang 050051, China
    4.Graduate School of Hebei Medical University, Shijiazhuang 050051, China
Yang Jie, E-mail: yjyyb313@163.com.

Received date: 2025-11-14

  Accepted date: 2025-12-31

  Online published: 2026-04-10

摘要

肝豆状核变性是临床上少见的经治疗可逆转的遗传代谢性疾病,早期诊断及尽早治疗是改善其预后的关键因素。血小板减少及脾大作为临床常见表现,特异性较低。其潜在的病因复杂多样,常涉及血液系统疾病、免疫系统疾病、消化系统疾病、感染性疾病及恶性肿瘤等多种疾病,这使其在临床诊断上常面临巨大挑战,极易导致误诊。该文深入分析了1例以血小板减少、脾大为首发症状的肝豆状核变性患者的病例资料,旨在提升临床医师在面对非特异性临床表现时,对潜在罕见疾病的诊断意识,从而避免误诊、漏诊,争取早期诊断和干预。

本文引用格式

闫晓倩 , 杨洁 , 杨永宾 , 陈钰 , 李燕 , 李杰 . 以血小板减少、脾大为首发表现的肝豆状核变性1例[J]. 上海交通大学学报(医学版), 2026 , 46(4) : 555 -560 . DOI: 10.3969/j.issn.1674-8115.2026.04.016

Abstract

Wilson's disease is a rare hereditary metabolic disorder that is reversible with treatment. Early diagnosis and timely treatment are critical factors in improving its prognosis. Thrombocytopenia and splenomegaly are common clinical manifestations but lack specificity. Their underlying causes are complex and diverse, often involving the hematologic system, immune system, digestive system, infectious diseases, and malignancies, which poses significant challenges in clinical diagnosis and easily leads to misdiagnosis. This article analyzes the clinical data of a case of Wilson's disease presenting with thrombocytopenia and splenomegaly as the initial manifestations, aiming to enhance clinicians' awareness of potential rare diseases when encountering non-specific clinical manifestations, thereby avoiding misdiagnosis and missed diagnosis and facilitating early diagnosis and intervention.

参考文献

[1] Kumar J, Roy I. Advancements in diagnostic approaches for Wilson's disease[J]. Anal Methods, 2025, 17(21): 4228-4250.
[2] Song J C, Liu S Y, Zhu F, et al. Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China[J]. Mil Med Res, 2020, 7(1): 15.
[3] 中华医学会肝病学分会遗传代谢性肝病协作组, 段钟平, 郑素军, 等. 肝豆状核变性诊疗指南(2022年版)[J]. 中华肝脏病杂志, 2022, 30(1): 9-20.
  Inherited Metabolic Liver Disease Collaboration Group, Chinese Society of Hepatology, Chinese Medical Association, Duan Z P, Zheng S J, et al. Guidelines for the diagnosis and treatment of hepatolenticular degeneration(2022 edition)[J]. Chinese Journal of Hepatology, 2022, 30(1): 9-20.
[4] Korga M, Pawlik P, Zaroda P, et al. Wilson's disease-clinical picture, factors influencing disease progression, treatment methods[J]. Qual Sport, 2024, 15: 51826.
[5] Lin S Z, Cai J L, Huang Y X, et al. Macrothrombocytopenia with leukocyte inclusions in a patient with Wilson disease: a case report and literature review[J]. BMC Med Genomics, 2024, 17(1): 188.
[6] Khodashahi M, Mohajeri N, Alipour M R, et al. A rare and intriguing case of Wilson's disease initially suspected of systemic lupus erythematosus[J]. Clin Case Rep, 2025, 13: e70091.
[7] Litwin T, Antos A, Bembenek J, et al. Neurological deterioration in Wilson's disease-types, etiology, course, and management[J]. Discov Med, 2024, 36(183): 646-654.
[8] Roy D, Mukherjee A, Chakravarty A. Pitfalls in the diagnosis of Wilson disease[J]. Curr Neurol Neurosci Rep, 2025, 25(1): 40.
[9] Tao Z, Zhou J F, Jiang Z Z, et al. Hepatolenticular degeneration-induced hepatic dysfunction with extremely atypical clinical manifestations: a case report[J]. Front Med, 2025, 12: 1599283.
[10] Garbuz M, Ovchinnikova E, Ovchinnikova A, et al. Spectrum of pathogenic variants of the ATP7B gene and genotype-phenotype correlation in eastern Eurasian patient cohorts with Wilson's disease[J]. Biomedicines, 2024, 12(12): 2833.
[11] Zhang S J, Yang W M, Li X, et al. Clinical and genetic characterization of a large cohort of patients with Wilson's disease in China[J]. Transl Neurodegener, 2022, 11(1): 13.
[12] Xue Z R, Chen H Y, Yu L, et al. A systematic review and meta-analysis of the R778L mutation in ATP7B with Wilson disease in China[J]. Pediatr Neurol, 2023, 145: 135-147.
[13] 夏俊珂, 宁昊丰, 罗晓, 等. 115例肝豆状核变性患者的基因型-表型关系和遗传学研究[J]. 中华肝脏病杂志, 2024, 32(6): 558-562.
  Xia J K, Ning H F, Luo X, et al. Genotype-phenotype relationship and genetics study of 115 cases with Wilson's disease[J]. Chinese Journal of Hepatology, 2024, 32(6): 558-562.
[14] Chen H, Wang X, Zhang J, et al. Effect of splenectomy based on inverse probability weighting of the propensity score on Wilson's disease with hypersplenism: a retrospective cohort study[J]. Exp Ther Med, 2023, 25(5): 220.
[15] Zhang W Z, Yu Q S, Peng H, et al. Clinical observation and risk assessment after splenectomy in hepatolenticular degeneration patients associated with hypersplenism[J]. Front Surg, 2022, 9: 972561.
[16] Beyzaei Z, Ghatei K, Shamsaeefar A, et al. Liver transplantation in Wilson disease: a single-center experience[J]. Orphanet J Rare Dis, 2025, 20(1): 292.
文章导航

/